The dopamine D2 receptor (DRD2) gene: A genetic risk factor in smoking

Pharmacogenetics

Volumn 6, Issue 1, 1996, Pages 73-79

  Comings, David E ^a   Ferry, Linda ^b   Bradshaw Robinson, Susan ^c   Burchette, R ^c   Chiu, C ^a   Muhleman, D ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Jerry L Pettis VA Hospital   (United States)

^c NONE

Author keywords

addiction; dopamine; DRD2; nicotine; receptors; smoking; tobacco

Indexed keywords

DOPAMINE 2 RECEPTOR;

ALLELE; ARTICLE; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; GENE; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SMOKING CESSATION; ADULT; CASE CONTROL STUDY; FEMALE; GENETICS; GENOTYPE; MALE; MIDDLE AGED; UNITED STATES;

ADULT; ALLELES; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D2; RISK FACTORS; SMOKING; UNITED STATES;

EID: 0029665628     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-199602000-00006     Document Type: Article

References (50)

1. Amadeo S, Abbar M, Fourcade ML, Waksman G, Leroux MG, Madec A, Selin M, Champiat J-C, Brethome A, Lcclaire Y, Castelnau D, Venisse J-L, Mallet J. D2 dopamine receptor gene and alcoholism. J Psychiatr Res 1993: 27, 173-179.
2. Barr CL, Kidd KK. Population frequencies of the A1 allele at the dopamine D2 receptor locus. Biol Psychiatry 1993: 34, 204-209.
3. Bartecchi CE, MacKenzie TD, Schrier RW. The human costs of tobacco use. New Engl J Med 1994: 330, 907-912.
4. Blum K, Noble EP, Sheridan PJ, Montgomery A, Ritchie T, Jadadeeswaran P, Nogami H, Briggs AH, Cohn JB. Allelic association of human dopamine D2 receptor gene in alcoholism. J Am Med Assn 1990: 263, 2055-2059.
5. Blum K, Braverman ER, Wood RC, Gill J, Li C, Chen TJH, Taub M, Montgomery AR, Sheridan PJ. Increased prevalence of the Taq I A1 allele of the dopamine D2 receptor gene (DRD2) in obesity with comorbid polysubstance abuse. Pharmacogenetics 1995a (in press).
6. Blum K, Wood RC, Sheridan PJ, Chen T, Comings DE. Dopamine D2 receptor gene variants: Association and linkage studies in impulsive, addictive and compulsive disorders. Pharmacogenetics 1995b: 5, 121-141.
7. Bolos AM, Dean M, Lucas-Derse S, Ramsburg M, Brown GL, Goldman D. Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. J Am Med Assn 1990: 26, 3165-3160.
8. Carmelli D, Swan GE, Robinette D, Fabsitz RR. Heritability of substance use in the NAS-NRC Twin Registry. Acta Genet Med Gemellol (Roma) 1990: 39, 91-98.
9. Carmelli D, Swan GE, Robinette D, Fabsitz R. Genetic influence on smoking - a study of male twins. New Engl J Med 1992: 327, 829-833.
10. Cigarette smoking among adults - United States. Morb Mortal Wkly Rep 1991: 39, 230-233.
11. Cigarette smoking-attributable mortality and years of potential life lost - United States. 1990. Morb Mortal Wkly Rep 1993: 41, 645-649.
12. Clarke PBS. Mesolimbic dopamine activation-the key to nicotine reinforcement? In: The biology of nicotine dependence. Chichester: Wiley (Ciba Foundation Symposium 152) 1990: pp. 153-161.
13. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. II. Alcohol abuse. Drug Alcohol Depend 1994a: 35, 17-24.
14. Comings DE. Genetic factors in substance abuse based on studies of Tourette syndrome and ADHD probands and relatives. I. Drug abuse. Drug Alcohol Depend 1994b: 35, 1-16.
15. Comings DE, Comings BG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Kane JM, Lieberman JA, Klein DN, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assn 1991: 266, 1793-1800.
16. Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R. The dopamine D2 receptor (DRD2) as a major gene in obesity and height. Biochem Med Metab Biol 1993: 50, 176-185.
17. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. The dopamine D2 receptor gene: A genetic risk factor in substance abuse. Drug Alcohol Depend 1994: 34, 175-180.
18. Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C, Dietz G, Gade R. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 1996 (submitted).
19. Corrigall WA, Coen KM. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berlin) 1989: 99, 473-478.
20. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985:9, 469-477.
21. DiChiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988: 85, 5274-5278.
22. DiFranza JK, Guerrera MP. Alcoholism and smoking. J Stud Alcohol 1990: 51, 130-135.
23. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987: 51, 227-233.
24. 2 receptor gene in alcoholism or schizophrenia. J Am Med Assn 1994: 271, 204-208.
25. Gelernter J, O'Malley SO, Risch N, Kranzler HR, Krystal J, Merikangas K, Kennedy JL, Kidd KK. No association between an allele at the D2 dopamine receptor gene (DRD2) and alcoholism. J Am Med Assn 1991: 266, 1801-1807.
26. Glassman AH, Helzer JE, Covey LS, Cottler L, Stetner F, Tipp J, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990: 264, 1546-1549.
27. Kapiro J, Hammer N, Koskenvuo M, Floderus-Myrhed B, Langinvainio H, Sarna S. Cigarette smoking and alcohol use in Finland and Sweden: a cross national twin study. Int J Epidemiol 1982: 11, 378-386.
28. 2 dopomine receptor A1 allele. Nature medicine 1995: 2.
29. Noble EP. The D2 dopamine receptor gene: A review of association studies in alcoholism. Behav Genet 1993: 23, 119-129.
30. Noble EP, Blum K, Ritchie T, Montgomery A, Sheridan PJ. Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry 1991: 48, 648-654.
31. Noble EP, Blum K, Khalsa H. Allelic association of the D2 dopamine receptor gene in cocaine dependence. CINP XVIIIth Congress 1992: Nice June 28-July 2 (Abstract).
32. 2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend 1993: 33, 271-285.
33. Noble EP, Jeor ST, Ritchie T, Syndulko K, Jeor SC, Fitch RJ, Brunner RL, Sparkes RS. D2 dopamine receptor gene and cigarette smoking: A reward gene? Med Hypoth 1994a: 42, 257-260.
34. Noble EP, Noble RE, Ritchie T, Grandy DK, Sparkes RS. D2 Receptor gene and obesity. Internat J Eating Disorders 1994b: 15, 205-217.
35. O'Hara BF, Smith SS, Bird G, Persico AM, Suarez B, Cutting GR, Uhl GR. Dopamine D2 receptor RFLPs, haplotypes and their association with substance use in Black and Caucasian research volunteers. Hum Genet 1993: 43, 209-218.
36. Parsian A, Todd RD, Devor EJ, O'Malley KL, Suarez BK, Reich T, Cloninger CR. Alcoholism and alleles of the human dopamine D2 receptor locus. Studies of association and linkage. Arch Gen Psychiatry 1991: 48, 655-663.
37. Robins LN, Heizer J, Croughan J, Ratclif KS. National Institute of Health diagnostic interview schedule. Arch Gen Psychiatry 1981: 38, 381-389.
38. Routtenberg A. The reward system of the brain. Sci Am 1978: 239, 154-165.
39. Sanders AR, Hamilton JD, Fann WE, Patel PI. Association of genetic variation at the porphobilinogen deaminase gene with schizophrenia. Am J Hum Genet 1991: 49 (Suppl), 358A.
40. Sarkar G, Kapelner S, Grandy DK, Marchionni M, Civelli O, Sobell J, Heston L, Sommer SS. Direct sequencing of the dopamine D2 receptor (DRD2) in schizophrenics reveals three polymorphisms but no structural change in the receptor. Genomics 1991: 11, 8-14.
41. Schelling T. Addictive drugs: The cigarette experience. Science 1992: 255, 430-433.
42. Schwab S, Soyka M, Niederecker N, Ackenheil M, Scherer J, Widenauer DB. Allelic association of human dopamine D2-receptor DNA polymorphism ruled out in 45 alcoholics. Am J Hum Genet 1991: 49 (Suppl). 203A.
43. Shiffman S. Tobacco "chippers'-individual differences in tobacco dependence. Psychopharmacology (Berlin) 1989: 97, 539-547.
44. Smith SS, O'Hara BF, Persico AM, Gorelick DA, Newlin DB, Vlahov D, Solomon L, Pickins R, Uhl GR. Genetic vulnerability to drug abuse. The D2 dopamine receptor Taq I B1 restriction fragment length Polymorphism appears more frequently in polysubstance abusers. Arch Gen Psychiatry 1992: 49, 723-727.
45. Suarez BK, Parsian A, Hampe CL, Todd RD, Reich T, Cloninger CR. Linkage disequilibria at the D2 dopamine receptor locus (DRD2) in alcoholics and controls. Genomics 1994: 19, 12-20.
46. Swan GE, Carmelli D, Rosenman RH. Smoking and alcohol consumption in adult male twins: genetic heritability and shared environmental influences. J Substance Abuse 1990: 2, 39-50.
47. Todd RD, O'Malley K, Parsian A, Simpson SG, DePaulo R. Bipolar affective disorder and alleles of the tyrosine hydroxylase locus. Psychiat Genet 1991: 2, 47-48.
48. Uhl GR, Smith SS, O'Hara BF, Persico AM, Bird GS, Markham LL. Taq I A and B D2 receptor RFLPs in polysubstance abusers. CINP XVIIIth Congress 1992: Nice June 28-July 2 (Abstract).
49. Vernon SW, Roberts RE. Use of the SADS-RDC in a tri-ethnic community survey. Arch Gen Psychiatry 1982: 39, 47-52.
50. Wise RA, Rompre PP. Brain dopamine and reward. Annu Rev Psychol 1989: 40, 191-225.